Ausgabe 3/2012
Inhalt (38 Artikel)
Case report and review of the literature: Secretory breast cancer in a 13-year-old boy—10 years of follow up
Cesar Cabello, Marcelo Alvarenga, Cesar Augusto Alvarenga, Giuliano Mendes Duarte, Patrick Nunes Pereira, Priscila Silva Marshall
Beyond taxanes: the next generation of microtubule-targeting agents
Javier Cortes, Maria Vidal
Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype
Aoife J. Lowery, Malcolm R. Kell, Ronan W. Glynn, Michael J. Kerin, Karl J. Sweeney
Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes
Muhammad Riaz, Els M. J. J. Berns, Anieta M. Sieuwerts, Kirsten Ruigrok-Ritstier, Vanja de Weerd, Arwin Groenewoud, Andrè G. Uitterlinden, Maxime P. Look, Jan G. M. Klijn, Stefan Sleijfer, John A. Foekens, John W. M. Martens
Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration
Sheng-Jun Liao, Yuan-Hong Zhou, Ye Yuan, Dong Li, Feng-Hua Wu, Qi Wang, Jian-Hua Zhu, Bin Yan, Jing-Jing Wei, Gui-Mei Zhang, Zuo-Hua Feng
Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival
Victor J. Weigman, Hann-Hsiang Chao, Andrey A. Shabalin, Xiaping He, Joel S. Parker, Silje H. Nordgard, Tatyana Grushko, Dezheng Huo, Chika Nwachukwu, Andrew Nobel, Vessela N. Kristensen, Anne-Lise Børresen-Dale, Olufunmilayo I. Olopade, Charles M. Perou
Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer
C. Panis, V. J. Victorino, A. C. S. A. Herrera, L. F. Freitas, T. De Rossi, F. C. Campos, A. N. Colado Simão, D. S. Barbosa, P. Pinge-Filho, R. Cecchini, A. L. Cecchini
Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma
Clint E. Johnson, Kylie L. Gorringe, Ella R. Thompson, Ken Opeskin, Samantha E. Boyle, Yuker Wang, Prue Hill, G. Bruce Mann, Ian G. Campbell
Local treatment of mixed osteolytic/osteoblastic spinal metastases: is photodynamic therapy effective?
L. Wise-Milestone, M. K. Akens, V. C. K. Lo, A. J. Yee, B. C. Wilson, C. M. Whyne
Expression of SPRR3 is associated with tumor cell proliferation in less advanced stages of breast cancer
Jin Cheon Kim, Jong Han Yu, Yoon Kyung Cho, Choon Sik Jung, Sei Hyun Ahn, Gyungyub Gong, Yong Sung Kim, Dong-Hyung Cho
Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction
M. Luz Flores, Carolina Castilla, Rainiero Ávila, Manuel Ruiz-Borrego, Carmen Sáez, Miguel A. Japón
Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes
Zsuzsanna Varga, Cathy B. Moelans, Ursina Zuerrer-Hardi, Constanze Ramach, Silvia Behnke, Glen Kristiansen, Holger Moch
High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer
M. P. H. M. Jansen, E. A. Reijm, A. M. Sieuwerts, K. Ruigrok-Ritstier, M. P. Look, F. G. Rodríguez-González, A. A. J. Heine, J. W. Martens, S. Sleijfer, J. A. Foekens, E. M. J. J. Berns
A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences
Abeer M. Shaaban, Graham R. Ball, Rebecca A. Brannan, Gabor Cserni, Anna Di Benedetto, Jo Dent, Laura Fulford, Helen Honarpisheh, Lee Jordan, J. Louise Jones, Rani Kanthan, Loaie Maraqa, Maria Litwiniuk, Marcella Mottolese, Steven Pollock, Elena Provenzano, Philip R. Quinlan, Georgina Reall, Sami Shousha, Mark Stephens, Eldo T. Verghese, Rosemary A. Walker, Andrew M. Hanby, Valerie Speirs
An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression
Natalie E. Simpson, Volodymyr P. Tryndyak, Frederick A. Beland, Igor P. Pogribny
Investigation of human JC and BK polyomaviruses in breast carcinomas
Mohamed Hachana, Khaled Amara, Sonia Ziadi, Riadh Ben Gacem, Sadok Korbi, Mounir Trimeche
A CD44−/CD24+ phenotype is a poor prognostic marker in early invasive breast cancer
Mohamed A. H. Ahmed, Mohammed A. Aleskandarany, Emad A. Rakha, Radwa Z. A. Moustafa, Ahmed Benhasouna, Christopher Nolan, Andrew R. Green, Mohammad Ilyas, Ian O. Ellis
Associated expressions of FGFR-2 and FGFR-3: from mouse mammary gland physiology to human breast cancer
Juan P. Cerliani, Silvia I. Vanzulli, Cecilia Pérez Piñero, María C. Bottino, Ana Sahores, Myriam Nuñez, Romina Varchetta, Rubén Martins, Eduardo Zeitlin, Stephen M. Hewitt, Alfredo A. Molinolo, Claudia Lanari, Caroline A. Lamb
Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia
Erik S. Knudsen, Adam Ertel, Elai Davicioni, Jessica Kline, Gordon F. Schwartz, Agnieszka K. Witkiewicz
GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells
Adele Vivacqua, Enrica Romeo, Paola De Marco, Ernestina Marianna De Francesco, Sergio Abonante, Marcello Maggiolini
Ethanol promotes mammary tumor growth and angiogenesis: the involvement of chemoattractant factor MCP-1
Siying Wang, Mei Xu, Feifei Li, Xin Wang, Kimberly A. Bower, Jacqueline A. Frank, Yanmin Lu, Gang Chen, Zhuo Zhang, Zunji Ke, Xianglin Shi, Jia Luo
A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer
Robert W. Carlson, Anne O’Neill, Tatiana Vidaurre, Henry L. Gomez, Sunil S. Badve, George W. Sledge
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab
Nancy U. Lin, Eric P. Winer, Duncan Wheatley, Lisa A. Carey, Stephen Houston, David Mendelson, Pamela Munster, Laurie Frakes, Steve Kelly, Agustin A. Garcia, Susan Cleator, Martina Uttenreuther-Fischer, Hilary Jones, Sven Wind, Richard Vinisko, Tamas Hickish
Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial
Adam Brufsky, Vicente Valero, Beatrice Tiangco, Shaker Dakhil, Arija Brize, Hope S. Rugo, Ragene Rivera, Anja Duenne, Naima Bousfoul, Denise A. Yardley
25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1
Eitan Amir, Reena S. Cecchini, Patricia A. Ganz, Joseph P. Costantino, Samantha Beddows, Nicola Hood, Pamela J. Goodwin
Recommendations for antiresorptive therapy in postmenopausal patients with breast cancer: Marburg AIBL Guideline Evaluation Study (MAGES)
Peyman Hadji, Melanie Hartenfels, Jannis Kyvernitakis, Olaf Hars, Klaus Heinrich Baumann, Matthias Kalder
Family history and risk of breast cancer: nurses’ health study
Graham A. Colditz, Kimberly A. Kaphingst, Susan E. Hankinson, Bernard Rosner
Association of CD27 and CD70 gene polymorphisms with risk of sporadic breast cancer in Chinese women in Heilongjiang Province
Fengyan Xu, Dalin Li, Qiujin Zhang, Zhenkun Fu, Weiguang Yuan, Da Pang, Dianjun Li
Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer
Nathan W. D. Lamond, Chris Skedgel, Daniel Rayson, Lynn Lethbridge, Tallal Younis
Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort
Serena Masciari, Deborah A. Dillon, Michelle Rath, Mark Robson, Jeffrey N. Weitzel, Judith Balmana, Stephen B. Gruber, James M. Ford, David Euhus, Alexandra Lebensohn, Melinda Telli, Stephen M. Pochebit, Georgios Lypas, Judy E. Garber
Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass
Henry M. Kuerer, Sara A. Lari, Banu K. Arun, Chung-Yuan Hu, Abenaa Brewster, Elizabeth A. Mittendorf, Constance T. Albarracin, Gildy V. Babiera, Abigail S. Caudle, Jamie L. Wagner, Jennifer K. Litton, Isabelle Bedrosian, Funda Meric-Bernstam, Anthony Lucci, Kelly K. Hunt
Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: The Korean Hereditary Breast Cancer (KOHBRA) Study
Byung Ho Son, Sei Hyun Ahn, Sung-Won Kim, Eunyoung Kang, Sue K. Park, Min Hyuk Lee, Woo-Chul Noh, Lee Su Kim, Yongsik Jung, Ku Sang Kim, Dong-Young Noh, Byung-In Moon, Young Jin Suh, Jeong Eon Lee, Doo Ho Choi, Sung Yong Kim, Sung Hoo Jung, Cha Kyong Yom, Hyde Lee, Jung-Hyun Yang
Recurrent germline mutations in BRCA1 and BRCA2 genes in high risk families in Israel
Yael Laitman, Monica Simeonov, Liron Herskovitz, Anya Kushnir, Shani Shimon-Paluch, Bella Kaufman, Jamal Zidan, Eitan Friedman
Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study
Daniel Prieto-Alhambra, Sonia Servitja, M. Kassim Javaid, Laia Garrigós, Nigel K. Arden, Cyrus Cooper, Joan Albanell, Ignasi Tusquets, Adolfo Diez-Perez, Xavier Nogues
Benign thyroid disease is associated with breast cancer: a meta-analysis
Prue J. Hardefeldt, Guy D. Eslick, Senarath Edirimanne
Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition
E. Rouleau, B. Jesson, A. Briaux, C. Nogues, V. Chabaud, L. Demange, J. Sokolowska, F. Coulet, E. Barouk-Simonet, Y. J. Bignon, F. Bonnet, V. Bourdon, M. Bronner, S. Caputo, L. Castera, C. Delnatte, C. Delvincourt, J. Fournier, A. Hardouin, D. Muller, J. P. Peyrat, C. Toulas, N. Uhrhammer, V. Vidal, D. Stoppa-Lyonnet, I. Bieche, R. Lidereau
Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients
Roberta Ferraldeschi, Monica Arnedos, Kristen D. Hadfield, Roger A’Hern, Suzie Drury, Andrew Wardley, Anthony Howell, D. Gareth Evans, Stephen A. Roberts, Ian Smith, William G. Newman, Mitch Dowsett
The biological correlates of macroscopic breast tumour structure measured using fractal analysis in patients undergoing neoadjuvant chemotherapy
P. Di Giovanni, T. S. Ahearn, S. I. K. Semple, L. M. Lovell, I. Miller, F. J. Gilbert, T. W. Redpath, S. D. Heys, R. T. Staff